Hans Hofland: Can NET become NEC (-like)?
Hans Hofland shared a post on X about a recent paper by Atsuko Kasajima et al. published in the Endocrine Pathology Journal.
“Can NET become NEC(-like)?
The answer is yes according to: Rapid Evolution of Metastases in Patients with Treated G3 Neuroendocrine Tumors Associated with NEC-Like Transformation and TP53 Mutation.”
Authors: Atsuko Kasajima, Nicole Pfarr, Eva-Maria Mayr, Ayako Ura, Elisa Moser, Alexander von Werder, Abbas Agaimy, Marianne Pavel and Günter Klöppel.
Hans Hofland is an internist-endocrinologist and Associate Professor at Erasmus MC Cancer Institute. He serves as the Chairman of the Dutch Belgian Neuroendocrine Tumor Society (DBNETS).
His research focuses on both translational and clinical aspects of endocrine oncology, specifically in the discovery and enhancement of biomarkers and the development of hormonal and radionuclide therapies for endocrine tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023